Angiodynamics (ANGO) Asset Writedowns and Impairment (2010 - 2026)
Angiodynamics (ANGO) reported Asset Writedowns and Impairment of -$90000.0 for Q1 2026, up 69.07% on a YoY basis from -$53231.7 in Q1 2025, and down 129.32% quarter-over-quarter from $307000.0 in Q4 2025.
Angiodynamics (ANGO) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Angiodynamics has reported Asset Writedowns and Impairment for 17 years, with the latest figure at -$90000.0 in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment rose 69.07% year-over-year to -$90000.0; the trailing twelve-month figure through Feb 2026 stood at $266000.0 (down 95.8% YoY), and the FY2025 full-year result was $173000.0, down 97.57% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at -$90000.0, down from $307000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $6.2 million in Q2 2024, with the low at -$291000.0 in Q1 2025.
- Historically, Asset Writedowns and Impairment has averaged $745533.3 across 5 years, with a median of $76000.0 in 2025.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment slumped 847.06% — and 2024, when it soared 2043.99%.
- Angiodynamics' Asset Writedowns and Impairment stood at -$45000.0 in 2022, then jumped by 2031.11% to $869000.0 in 2023, then plunged by 57.65% to $368000.0 in 2024, then decreased by 16.58% to $307000.0 in 2025, then plunged by 129.32% to -$90000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at -$90000.0 (Q1 2026), $307000.0 (Q4 2025), and -$27000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Angiodynamics | 505.81 Mn | 468.00 Mn | 41.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -90,000.00 |
| Feb 28, 2026 | -90,000.00 |
| Nov 30, 2025 | 307,000.00 |
| Nov 30, 2025 | 307,000.00 |
| Aug 31, 2025 | -27,000.00 |
| Aug 31, 2025 | -27,000.00 |
| May 31, 2025 | 76,000.00 |
| May 31, 2025 | 76,000.00 |
| Feb 28, 2025 | -291,000.00 |
| Feb 28, 2025 | -291,000.00 |
| Nov 30, 2024 | 368,000.00 |
| Nov 30, 2024 | 368,000.00 |
| Aug 31, 2024 | 20,000.00 |
| Aug 31, 2024 | 20,000.00 |
| May 31, 2024 | 6.24 Mn |
| May 31, 2024 | 6.24 Mn |
| Feb 29, 2024 | 3.40 Mn |
| Feb 29, 2024 | 3.40 Mn |
| Aug 31, 2023 | 869,000.00 |
| Aug 31, 2023 | 869,000.00 |